3652 results for «287»
3652 results
OCT and artificial intelligence: a new shiny light for better decision making in complex coronary interventions
15 Dec 2022 – From GulfPCR-GIM 2022
Watch this case-in-point presentation focusing on decision-making in complex PCI using OCT plus AI to understand how to take the right measurement throughout the procedure, how artificial intelligence aids in decision making during imaging-guided PCI, and to gain skills in interpreting OCT imaging, among others!
Tricuspid regurgitation: a new prospect in the management of patients with TR
15 Dec 2022 – From GulfPCR-GIM 2022
Thanks to this GulfPCR-GIM 2022 session, get to understand how the TricValve can help in the management of patients with functional TR, know more about the TricValve Bicaval Valves system, and gain insight into the early adoption experience in the Middle East.
Optimising immediate and long-term outcomes after TAVI
15 Dec 2022 – From GulfPCR-GIM 2022
This session focuses on the use of the Acurate Neo2 valve in daily practice: watch it if you wish to learn how to determine clinical scenarios where the valve in question would be the best option, to find out more about lifetime management of AS patients...
Another frontier crossed!
15 Dec 2022 – From GulfPCR-GIM 2022
Watch this session to find out more about the optimal approach to complex patients, to learn about optimal plaque modification techniques, including atherectomy, to discuss the approach to severely calcified lesions, and to know more about the added value of intravascular imaging.
Managing a high bleeding risk patient undergoing PCI
15 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, analyse the cases of a 76-year-old female patient with asthma, angina on exertion, multiple calcific tandem lesions in the LAD and LCX, and minimal RCA disease, and of a 48-year-old male patient, smoker, with ACS in 2012 and 2020, who presented with...
Stable CAD - Tools, devices and techniques
14 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, 3 cases of stent loss are presented, as well as a remote robotic DK Crush in a 3D printed anatomy, and an onion-shaped stent layer in an in-stent restenosis patient.
Challenging CTO Cases - Session 1
14 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, learn about a complex challenging case of left main bifurcation disease and ostial left anterior descending CTO, as well as a rotational atherectomy assisted-PCI for an old calcified CTO, and more!
Challenging TAVI scenarios
14 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session is for you if you want to learn more about recurrent valve migration during TAVR or TAVI with permanent pacemaker implantation, among others!
Challenging CTO cases - Session 2
14 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session compiles 5 challenging CTO cases and explains how to handle them. Study for example a flush ostial RCA-CTO, PWS in a CTO feeding vessel, rotablation and intravascular lithotripsy in three-vessel disease with IVUS, or rotaburr incarceration.
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...

Author
EuroPCR 2025 – Meta-Analysis of Individual Patient Data from the PROTECTED TAVR and BHF PROTECT-TAVI Trials
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among which is the...
Surgical left atrial appendage occlusion in VHD without AF: OPINION Trial
03 Sep 2025
Alex Sticchi provides his take on the results of the OPINION trial presented by Yang Wang at the ESC Congress 2025 in Madrid.

Author